Skip to main content

Animations

MJFF Publications

3741 - 3750 of 6456 Results
Title
Year
  • Year
  • 2021
  • 2025
  • 2020
  • 2019
  • 2019
  • 2024
  • 2019
  • 2025
  • 2021
  • 2018
  • Summary Details
    OPEN
    Title: Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100113
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Evaluating the Role of α‐Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.70434
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-42535-w
    Citation Count: 48
  • Summary Details
    OPEN
    Title: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death
    Journal Name: Redox Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.redox.2019.101377
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Tetrabenazine‐induced acute dystonic reaction during the treatment of comorbid tics in a young woman with autism spectrum disorder
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/pcn.13705
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 45
  • Summary Details
    OPEN
    Title: N-type Ca2+ channels mediate the stimuli-dependent α-synuclein secretion in mouse striatum
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01110-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data
    Journal Name: Microbiome
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40168-020-00993-9
    Citation Count: 196
  • Summary Details
    OPEN
    Title: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1
    Citation Count: 128
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.